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Abstract
Purpose
The maintenance of full bladder is important to reduce radiation-induced toxicities and main-
tain the therapeutic consistency in locally advanced rectal cancer patients who underwent
radiotherapy (RT). So, the aim of this study was to evaluate the effectiveness of protocol-
based full bladder maintenance by assessing bladder volume variation using an ultrasound
bladder scanner to maintain bladder volume.
Materials and Methods
From March 2011 to May 2011, twenty consecutive rectal cancer patients receiving external
beam RT participated in this prospective study. Protocol-based full bladder maintenance
consisted of education, training and continuous biofeedback by measuring bladder volume.
Bladder volume was measured by bladder scan immediately before simulation CT scan and
before each treatment three times weekly during the RT period. The relative bladder volume
change was calculated. Intra-patient bladder volume variations were quantified using inter-
quartile range (IQR) of relative bladder volume change in each patient. We compared intra-
patient bladder volume variations obtained (n=20) with data from our previous study pa-
tients (n=20) performing self-controlled maintenance without protocol.
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Results
Bladder volumesmeasured by bladder scan highly correlated with those on simulation CT
scan (R=0.87, p<0.001). Patients from this study showed lower median IQR of relative blad-
der volume change compared to patients of self-controlled maintenance from our previous
study, although it was not statistically significant (median 32.56% vs. 42.19%, p=0.058). Upon
logistic regression, the IQR of relative bladder volume change was significantly related to pro-
tocol-basedmaintenance [relative risk 1.045, 95% confidence intervals (CI) 1.004-1.087,
p=0.033]. Protocol-based maintenance included significantly more patients with an IQR of rel-
ative bladder volume change less than 37% than self-controlled maintenance (p=0.025).
Conclusion
Our findings show that bladder volume could be maintained more consistently during RT by
protocol-based management using a bladder scan.
Introduction
Preoperative chemoradiation (CRT) is a standard treatment for locally advanced rectal cancer,
which increases local control and sphincter preservation rates compared with adjuvant treat-
ments [1–4]. Additionally, for rectal cancer patients with adverse pathologic factors such as
T3-4 or positive lymph nodes, postoperative CRT is required to improve treatment outcome
[5]. Generally, pelvic irradiation for rectal cancer patients is safe and tolerable.
Small bowel damage is a common treatment-related complication for rectal cancer patients
receiving CRT. It is known that the risk of gastrointestinal (GI) toxicities is related with irradi-
ated small bowel volume and the dose within the radiation field [6]. In some cases, patients de-
velop acute toxicities such as nausea, vomiting, abdominal pain, and abnormal absorption, as
well as chronic toxicities including bowel obstruction, perforation, and intestinal stricture. In
preoperative CRT for rectal cancer, grade 3 or 4 acute toxicity and diarrhea is reported to devel-
op in 12~36% of patients, whereas long-term GI toxicity occurs in 9% of patients [2,7,8]. Simi-
larly, 18~35% of patients receiving postoperative CRT are reported to have severe acute
toxicity and 5~15% of patients have late toxicity related to small bowel damage [2,7,9,10].
Therefore, many investigators have attempted to reduce the irradiated dose of small bowel
using non-surgical methods such as the prone position, as well as small bowel displacement de-
vices like the belly board and bladder distension [11,12]. Since 2009, our institution has treated
all rectal cancer patients by distending the bladder fully with a belly board in the prone position
preoperatively or postoperatively.
However, after CT simulation with a full bladder volume, patients find it very difficult to
maintain the bladder volume similar to that of the simulation CT during the entire duration (5
to 6 weeks) of radiotherapy (RT). Some studies using ultrasound bladder scanner for cervical
or prostate cancer reported large variations of bladder volume but noted the bladder scanner
was useful and accurate to assess the inter-fractional variation of bladder volume [13–16]. Our
institution has assessed bladder volume every other day using a bladder scanner since February
2011 and in our previous pilot study, we reported that there were bladder volume variations
and reductions in bladder volume in rectal cancer patients receiving CRT [17]. It was previous-
ly reported that biofeedback could improve the consistency of bladder volume despite a lack of
statistical significance [16]. Thus, the purpose of this prospective study was to evaluate the
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usefulness of protocol-based full bladder maintenance by assessing variations of bladder vol-
ume using an ultrasound bladder scanner to maintain the bladder volume during radiation for
locally advanced rectal cancer.
Materials and Methods
Patients
This prospective observational study received approval from the Severance internal review
boards of the Severance hospital (IRB No. 4-2010-0832). FromMarch 2011 to May 2011, twen-
ty consecutive rectal cancer patients receiving external beam RT participated in this study and
provided written informed consent. The inclusion criteria of this study were as follows: age
20 years with planned preoperative or postoperative RT for locally advanced rectal cancer.
We excluded patients who had urinary frequency of more than once per hour, nocturia more
than 4 times per day, urinary incontinence, median laparotomy scar or lymphocele interfering
with bladder scanning, aberrant bladder form, or poor compliance. Patient characteristics are
listed in Table 1.
Chemoradiotherapy
CT simulation and treatment were performed with the patient with a full bladder in a prone
position with a belly board [18]. All patients received CRT consisting of 3-dimensional confor-
mal RT (3D-CRT). Treatment planning was accomplished with Pinnacle3 (Philips Medical Sys-
tems, Andover, MA). Target volumes and critical adjacent organs, including the bladder and
small bowel, were delineated by the attending radiation oncologists. The clinical target volume
included the primary tumor mass or postoperative tumor bed, mesorectum, presacral space, as
well as the pelvic lymph nodes and/or external iliac lymph nodes if indicated. For the whole
pelvic field, the superior border was defined as the L5-S1 interspace, the inferior border as 3–4
cm below the primary tumor or inferior border of obturator foramen, and the lateral border as
1.5 cm behind the true bony pelvis. For the lateral fields, we defined the anterior border as the
posterior margin of the symphysis pubis and the posterior border as the anterior bony sacral
margin. In case of a tumor extending directly to a pelvic organ with external drainage, we mod-
ified the anterior border to the anterior border of the symphysis pubis to include the external
iliac lymphatics. The 3D-CRT consisted of 41.4–45 Gy of whole pelvic RT and 4.5–9.0 Gy of
local boost RT to the postoperative tumor bed or primary tumor. The median total dose was
50.4 Gy (range, 45–54). Concurrent intravenous chemotherapy was administered with a
5-fluorouracil (425 mg/m2) and leucovorin (20 mg/m2) bolus on weeks 1 and 5 of 3D-CRT.
Protocol-based full bladder maintenance by education, training, and
continuous biofeedback
Protocol-based full bladder maintenance consisted of education, training and continuous bio-
feedback by measuring bladder volume. The specific bladder-filling instructions regarding
comfortably full bladder were given as follows. First, immediately after patients void the blad-
der, they drink 500 ml water to have a comfortably full bladder. Second, patients wait until
they have a definite but easily tolerable micturition urge (grade 3) or intolerable micturition
urge (grade 4). Third, patients record each duration of grade 3 or grade 4 micturition urge in a
micturition diary. Fourth, patients visit the hospital at an intermediate status (between grade 3
and 4 of micturition urge) to have a comfortably but maximally full bladder. Until the date of
CT simulation, patients were asked to train at least twice according to these specific instruc-
tions. Next, all patients were additionally trained three times a week (Monday, Wednesday,
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and Friday) during the 5- or 6-week RT course according to the biofeedback protocol. The aim
of the biofeedback protocol was to improve the constancy of bladder volume measured on
bladder scan. We attempted to improve the ability of patients to detect bladder-filling sensa-
tions, similar to bladder fullness on simulation CT scan. The feedback consisted of advising pa-
tients to drink more water or suppress urination longer according to their daily bladder
volume. When the bladder volume of patients ranged from 80% to 120% of that of the simula-
tion CT scan, patients were instructed to keep the same pattern of bladder filling the following
day. When the bladder volume was less than 80% of that of the simulation CT scan, patients
Table 1. Patient characteristics.
Characteristics n (%)
Age (years) Median 56
Range (22–73)
Gender Female 6 (30.0)
Male 14 (70.0)
Performance status ECOG PS 0 8 (40.0)
ECOG PS 1 12 (60.0)
Distance from AV (cm) Median 7
Range (3–12)
Tumor location Lower rectum 8 (40.0)
Mid rectum 6 (30.0)
Upper rectum 6 (30.0)
Pathology Adenocarcinoma 20 (100.0)
Tumor grade WD 4 (20.0)
MD 15 (75.0)
PD 0 (0.0)
Unknown 1 (5.0)
Aim of radiotherapy Preoperative 13 (65.0)
Postoperative 7 (35.0)
Clinical T stage for preoperative RT T2 2 (15.4)
T3 10 (76.9)
T4 1 (7.7)
Clinical N stage for preoperative RT N0 3 (23.1)
N1 1 (7.7)
N2 9 (69.2)
Pathologic T stage for postoperative RT T2 2 (28.6)
T3 5 (71.4)
T4 0 (0.0)
Pathologic N stage for postoperative RT N0 2 (28.6)
N1 3 (42.9)
N2 2 (28.6)
RT dose (Gy) Median 50.4
Range (45–54)
Fractional dose (Gy) Median 1.8
Range (1.8–2.0)
Patient characteristics are listed.
Abbreviations: ECOG PS = Eastern Cooperative Oncology Group Performance Status Scale; WD = well differentiated; MD = moderately differentiated;
PD = poorly differentiated; RT = radiotherapy
doi:10.1371/journal.pone.0128791.t001
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were instructed to drink 100 or 200 ml more fluid or to suppress urination longer. When the
bladder volume was less than 50% of the simulation CT scan volume, patient was advised to
suppress urination for 30 minutes to 1 hour. When the measurement was greater than 120% of
the simulation CT scan, patients were advised to drink less.
Bladder volume measurements
Using a portable automated ultrasonic bladder scanner (Biocon-700, Mcube Technology,
Korea), bladder volume was measured by two experienced physicians immediately before the
simulation CT scan as well as prior to treatment during 5 or 6 weeks of RT. Patients were com-
fortably positioned in a supine position. Next, the operator placed the scanner probe on two
fingers over the symphysis pubis at the midline of abdomen and angled the probe towards the
bladder. Operators checked the three-dimensional real time image before scanning to locate
the bladder position for more accurate measurement. Each bladder scan time and bladder vol-
ume (ml) measured by the bladder scanner was documented. Before simulation CT, the blad-
der was scanned consecutively 5 times, and the median value was recorded as the baseline
bladder volume. The bladder volume was also calculated using the contour of bladder inner
wall based on the simulation CT images. During the entire treatment period, each patient’s
bladder was scanned 3 days per week (Monday, Wednesday, and Friday) just prior to RT, and
5 times daily to report the median value. Each ultrasound scan required approximately 1–2
min and the addition of an ultrasound scan did not affect overall treatment time.
Toxicity evaluation and follow-up
Patients were prospectively followed up at 1 and 3 months following the completion of RT,
then every 3 months during the first 2 years after RT, and every 6 months from the third year.
Treatment-related adverse events were evaluated according to the National Cancer Institute
Common Toxicity Criteria (version 3.0).
Statistical analyses
When bladder volume measurement data was missing for any reason, we replaced the missing
values for bladder volume measured using the last observation carried forward (LOCF) meth-
od. Eighteen patients (90%) completed planned measurement of bladder volume according to
schedule. In two patients, bladder volume measurement data was missing, (one data in one pa-
tient and five data in the other). In order to assess the accuracy of bladder ultrasound scan, the
correlation between the bladder volume measured by bladder scanner and the bladder volume
calculated using simulation CT images was analyzed using Pearson’s correlation tests. The
bladder volumes during the RT and the baseline bladder volumes measured by bladder ultra-
sound scan before CT simulation were compared using Wilcoxon signed-rank tests. To evalu-
ate the protocol-based full bladder maintenance, we compared 20 patients from this study with
20 patients performing self-controlled maintenance without protocol-based education, training
and continuous biofeedback from our previous study [17]. The relative bladder volume change
of all patients was calculated using the following equation:
Relative bladder volume change %ð Þ
¼ Bladder volume during RT mlð Þ  Baseline bladder volume mlð Þ
Baseline bladder volume mlð Þ  100
We calculated the interquartile range (IQR) of relative bladder volume change for each pa-
tient in this study and each patient in the previous study. Intra-patient bladder volume
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variations were quantified by IQR of relative bladder volume change in each patient. Next, we
compared relative bladder volume change and IQR of relative bladder volume change of each
patient between two studies using Mann-Whitney U tests. For further evaluation of the effect
of protocol-based full bladder maintenance on improvement of the intra-patient bladder vol-
ume variations, we analyzed the correlation between IQR of relative bladder volume change
and protocol-based full bladder maintenance using binary logistic regression for a total of 40
patients from this and previous studies. We determined the cut-off value of IQR of relative
bladder volume change for protocol-based full bladder maintenance using receiver operating
characteristic (ROC) curves. The 40 patients were divided into two groups according to the
cut-off value. We performed Chi-square tests to investigate the impact of protocol-based full
bladder maintenance on the two groups according to the cut-off value. Statistical significance
was defined as p<0.05, and SPSS 20.0.0 (IBM Corporation, Armonk, New York, USA) was
used for all analyses.
Results
Treatment-related acute and chronic toxicity
Most acute and chronic toxicities in this prospective study were mild (grade 0–2). Grade 4 or
5 acute toxicity was not observed in any patient. Eleven of the patients (55%) experienced
grade 3 diarrhea, five patients (25%) had acutely grade 3 tenesmus, and one patient (5%) had
a grade 3 skin rash (Table 2). Grade 4 or 5 chronic toxicity was also not observed in any pa-
tient. No patients experienced grade 3 chronic toxicity, excepting 3 patients (15%) with grade
3 diarrhea (Table 3).
Bladder volume measurement validation
All patients received bladder ultrasound scans a median of 16 times (range: 15–18; 3 days a
week according to the RT schedule). All patients received prearranged scans a median of 16
times (range: 11–18). The median bladder volume on simulation CT image was 450 ml (IQR
195, range: 264–860). The median volume measured by bladder ultrasound scanner before
simulation CT scan on the same day was 398 ml (IQR 240; range: 264–821). We observed that
Table 2. Prospective evaluation of acute toxicity (n = 20).
Grade 0 Grade 1 Grade 2 Grade 3 Grade 4
Nausea 15 75% 4 20% 1 5% 0 0% 0 0%
Vomiting 0 0% 0 0% 0 0% 0 0% 0 0%
Fatigue 3 15% 13 65% 4 20% 0 0% 0 0%
Weight loss 18 90% 2 10% 0 0% 0 0% 0 0%
Anorexia 6 30% 12 60% 2 10% 0 0% 0 0%
Diarrhea 3 15% 1 5% 5 25% 11 55% 0 0%
Tenesmus 9 45% 3 15% 3 15% 5 25% 0 0%
Incontinence, anal 17 85% 3 15% 0 0% 0 0% 0 0%
Skin rash 15 75% 4 20% 0 0% 1 5% 0 0%
Cystitis 17 85% 3 15% 0 0% 0 0% 0 0%
Incontinence, urinary 0 0% 0 0% 0 0% 0 0% 0 0%
Abdominal pain 16 80% 3 15% 1 5% 0 0% 0 0%
The data of acute toxicity are listed.
doi:10.1371/journal.pone.0128791.t002
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bladder volumes measured by bladder scan highly correlated with those on simulation CT scan
(R = 0.87, p<0.001, Fig 1).
Time trends of bladder volume measured using bladder ultrasound scan
The bladder volume measurements and the number of patients adjusted by LOCF according to
time sequence are described in Table 4. Due to missing data, we used LOCF from V4-2 to V5-3.
Table 3. Prospective evaluation of late toxicity (n = 20).
Grade 0 Grade 1 Grade 2 Grade 3 Grade 4
Nausea 20 100% 0 0% 0 0% 0 0% 0 0%
Vomiting 0 0% 0 0% 0 0% 0 0% 0 0%
Fatigue 14 70% 6 30% 0 0% 0 0% 0 0%
Weight loss 20 100% 0 0% 0 0% 0 0% 0 0%
Anorexia 15 75% 5 25% 0 0% 0 0% 0 0%
Diarrhea 10 50% 3 15% 4 20% 3 15% 0 0%
Tenesmus 15 75% 2 10% 3 15% 0 0% 0 0%
Incontinence, anal 16 80% 4 20% 0 0% 0 0% 0 0%
Skin rash 20 100% 0 0% 0 0% 0 0% 0 0%
Cystitis 20 100% 0 0% 0 0% 0 0% 0 0%
Incontinence, urinary 0 0% 0 0% 0 0% 0 0% 0 0%
Abdominal pain 20 100% 0 0% 0 0% 0 0% 0 0%
The data of chronic toxicity are listed.
doi:10.1371/journal.pone.0128791.t003
Fig 1. Correlation of bladder volumemeasured using a bladder scan and simulation CT scan. This
figure depicts that bladder volumes measured by bladder scan highly correlated with those on simulation CT
scan (R = 0.87, p<0.001).
doi:10.1371/journal.pone.0128791.g001
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Compared to baseline bladder volume by bladder scan, all median values of bladder volumes
measured during RT were significantly lower (p<0.05), except the first scan after the start of
treatment (p = 0.087, Table 4).
Assessment of intra-patient variation according to protocol-based
maintenance
The median values and IQRs of relative bladder volume change of each patient from this and
our previous study patients were calculated (Table 5). Comparing median intra-patient relative
bladder volume change between current and previous study, protocol-based full bladder main-
tenance group showed less bladder volume reduction than self-controlled maintenance group
although a difference is not statistically significant (median 27.4% reduction in current study
vs. 32.9% reduction in previous study, p = 0.55). To evaluate intra-patient variation, we investi-
gated the difference between median values of each patient’s IQR of relative bladder volume
change between patients receiving protocol-based full bladder maintenance (n = 20) and pa-
tients from the previous study who performed self-controlled full bladder maintenance
(n = 20). Patients from this study receiving protocol-based maintenance showed lower median
IQR of relative bladder volume change although a difference is not statistically significant [me-
dian 32.56% (range 18.03–61.09) vs. 42.19% (range 17.79–96.6), p = 0.058]. In Fig 2, we ob-
served that patients receiving no protocol-based maintenance had wider IQR ranges of relative
bladder volume change. Therefore, to further evaluate the correlation between IQR of relative
Table 4. Time trends of bladder volume from CT scans and bladder scans.
No. of patients Median volume (ml) IQR Range (ml) p valuea
VCT 20 450 195 264–860 -
VB-SCAN 20 398 240 264–821 -
V1-1 week 20 319 234 147–929 0.087
V1-2 week 20 306 146 60–734 0.001
V1-3 week 20 270 135 50–561 0.001
V2-1 week 20 371 161 136–642 0.017
V2-2 week 20 300 154 219–536 0.002
V2-3 week 20 358 196 173–488 0.01
V3-1 week 20 348 166 124–634 0.03
V3-2 week 20 268 62 147–606 <0.001
V3-3 week 20 317 179 126–557 0.014
V4-1 week 20 333 144 117–528 0.006
V4-2 week 20 252 182 134–532 0.001
V4-3 week 20 272 122 84–482 0.001
V5-1 week 20 336 140 147–485 0.003
V5-2 week 20 277 182 98–528 <0.001
V5-3 week 20 282 130 137–511 <0.001
V6-1 week 17 284 65 130–436 0.002
V6-2 week 8 335 130 216–560 0.025
V6-3 week 7 258 266 149–448 0.018
The bladder volume measurements and the number of patients adjusted by LOCF according to time sequence are described.
a p value between VB-SCAN and Vx-x week
Abbreviations: IQR = interquartile range; VCT = bladder volume measured from simulation CT scans; VB-SCAN = bladder volume scanned by bladder
scan prior to simulation CT scans; Vx-x week = bladder volume scanned by bladder scan at post-RTx-x week.
doi:10.1371/journal.pone.0128791.t004
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Table 5. Relative bladder volume change for each patient.
Patient Current study (protocol-based
maintenance)
Previous study (self-controlled
maintenance)
Median (%) IQR (%) Median (%) IQR (%)
Case 1 -19.66 52.52 -35.10 17.79
Case 2 -40.72 26.17 -56.15 19.49
Case 3 1.71 30.82 -67.60 21.81
Case 4 4.55 61.09 -66.95 24.36
Case 5 5.30 27.46 -68.24 31.42
Case 6 -27.45 42.84 -55.50 31.92
Case 7 -53.96 21.16 -41.99 33.12
Case 8 -31.15 20.49 -9.17 34.86
Case 9 -27.42 18.02 -26.67 39.63
Case 10 -38.17 36.98 -65.69 41.42
Case 11 -18.35 24.73 -26.90 42.95
Case 12 -51.83 26.19 -76.04 45.64
Case 13 -24.04 35.91 23.03 51.69
Case 14 -41.90 34.29 -33.12 57.25
Case 15 -51.55 21.78 -32.43 66.41
Case 16 -35.75 49.74 0.00 76.08
Case 17 7.76 56.83 41.27 76.51
Case 18 -22.91 34.97 -0.88 76.55
Case 19 -15.52 23.58 73.62 78.21
Case 20 -46.20 34.70 77.55 96.60
The median values and interquartile ranges of relative bladder volume change of each patient from this and
our previous study patients are described.
Abbreviations: IQR = interquartile range
doi:10.1371/journal.pone.0128791.t005
Fig 2. The distribution of interquartile range of relative bladder volume change according to protocol-
basedmaintenance. The interquartile range of relative bladder volume change for patients receiving
protocol-based full bladder maintenance (black squares) had smaller variation than that of patients
performing self-controlled maintenance (open triangles).
doi:10.1371/journal.pone.0128791.g002
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bladder volume change and protocol-based maintenance, we performed binary logistic regres-
sion. Upon logistic regression, the IQR of relative bladder volume change was significantly re-
lated to protocol-based maintenance [relative risk 1.045, 95% confidence intervals (CI) 1.004–
1.087, p = 0.033]. We calculated cut-off values of IQR of relative bladder volume change for
protocol-based maintenance using ROC curve analysis (AUC 0.68, 95% CI 0.51–0.85) and de-
termined 37% as a cut-off value (Table 6). Using Chi-square tests, the current study included
significantly more patients with an IQR of relative bladder volume change less than 37% than
our previous study (p = 0.025, Table 6).
Discussion
The findings from this prospective study showed that although absolute values of bladder vol-
ume measured by bladder scans differed from bladder volume on simulation CT scan, there
was significant positive correlation between bladder volumes of simulation CT and bladder ul-
trasound scans. Bladder scan is a useful and accurate device to measure bladder volume easily.
During the entire RT course for rectal cancer, there was significant reduction and a wide range
of variation in bladder volume compared to baseline bladder volume, despite protocol-based
education, bladder filling training and continuous biofeedback. However, this study demon-
strated that compared to our previous study, protocol-based full bladder maintenance could re-
duce the intra-patient variation of bladder volume during the RT course and improve the
consistency of bladder volume.
This study has some special considerations. First, this study is an observation study. In addi-
tion, we used patients in the preliminary study as a control group, which may lower the quality
of data in the control group due to the lack of experience using the bladder scanner in the initial
stages of the preliminary study. However, bladder scans and CT bladder volumes were highly
correlated in the control group, and patients in the control group fit the inclusion criteria of this
study. Therefore, we consider our results are sufficient to show the importance of protocol-
based full bladder maintenance. For a more accurate study, further randomized trials are neces-
sary to study the effect of protocol-based maintenance. Second, basic bladder function tests were
not performed on patients enrolled in this study. However, we excluded patients with micturi-
tion problems and no patient showed micturition problems during the study period. Any patient
with mild or severe urinary frequency or nocturia was not included in this study. Thus, the ab-
sence of basic bladder function tests in this study likely did not significantly impact the results of
this study. Third, there was no significant difference of median relative bladder volume change
of each patient between two groups due to small number of enrolled patients. But, we consider
that despite small number of patients, our findings showed less bladder volume reduction com-
pared to initial planning and day-to-day variation through protocol-based bladder volume
maintenance. Forth, in the era of intensity-modulated RT (IMRT), the protocol-based full blad-
der maintenance might be less applicable and important since IMRT could reduce radiation-in-
duced toxicity for rectal cancer patients. Nevertheless, we consider that the addition of full
Table 6. Biofeedback effect relative to bladder volume consistency.
Variables Current study (protocol-based maintenance) Previous study (self-controlled maintenance) p value
IQR of RBVC <37 15 (75.0) 8 (40.0) 0.025
IQR of RBVC 37 5 (25.0) 12 (60.0)
The current study included signiﬁcantly more patients with an interquartile range of relative bladder volume change less than 37% than our previous study.
Abbreviations: IQR = interquartile range; RBVC = Relative bladder volume change
doi:10.1371/journal.pone.0128791.t006
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bladder maintenance to IMRT could help minimize irradiated dose to organs at risk and radia-
tion-induced toxicity in IMRT for rectal cancer. In this context, further study about the applica-
bility of bladder scanner in IMRT for rectal cancer would be needed. Considering these
limitations, properly designed randomized trial with more patients should be needed.
In a previous study from another institute, the usefulness of a bladder scan to achieve better
reproducibility of bladder filling during pelvic RT was evaluated [16]. These authors showed
that daily bladder volume variation was not significantly improved by biofeedback protocols
by comparing the control and feedback group (47.2% and 40.1%, respectively, p = 0.2). Howev-
er, although not statistically significant, bladder volume during RT was better, and daily blad-
der volume variations were smaller, in the feedback group. This was perhaps due to reasons
such as baseline micturition problems of prostate cancer patients. Similarly, another study of
prostate patients also reported large bladder volume variance [19]. However, although a small
number of patients were evaluated, we enrolled rectal cancer patients without baseline micturi-
tion problems according to strict inclusion and exclusion criteria. In addition, we used a more
definitive and objective biofeedback protocol. Thus, in rectal cancer patients without baseline
micturition problems, we consider that definitive protocol-based continuous biofeedback
training of bladder filling using bladder ultrasound scan can improve bladder volume consis-
tency during the RT course, thereby maintaining effective and safe treatment.
Our findings showed that bladder scans were fairly accurate in measuring bladder volume
compared to bladder volume on simulation CT scan. Other previous studies have also reported
that there was a strong correlation between bladder ultrasound scan and simulation CT scan
[14–16]. Because CT scan cannot be performed every day or weekly during the entire treatment
period, bladder scans can be utilized as an easy, convenient, and useful tool to check bladder
volume and allow steady biofeedback training progress. However, we managed the full bladder
maintenance protocol using bladder scans and improved bladder volume consistency during
RT, and bladder volume during RT period was still significantly lower than baseline bladder
volume. Ahmed et al. also reported that bladder volumes were dramatically reduced during
treatment despite of full bladder training [14]. Thus, it is necessary to develop and evaluate ad-
ditional methods or materials to reduce the differences in absolute bladder volume between
baseline and the RT period.
Conclusions
In conclusion, we report that it would be possible to maintain bladder volume steadily during
the entire RT course through protocol-based education, training, and continuous biofeedback
and bladder scan utilization. Further study will be required to critically evaluate the influence
of protocol-based full bladder maintenance, and additional methods need to be studied for im-
proved consistency of bladder volume.
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